Big Pharma boss caught giving execs two middle fingers after they complain about EpiPen price gouging: report
Mylan is still facing public outrage over its decision to jack up EpiPen prices, but a new report from the New York Times claims that Mylan’s chairman isn’t worried about the backlash at all.
Continue Reading http://www.rawstory.com
Join the Discussion